Literature DB >> 9351807

The crystal structure of vascular endothelial growth factor (VEGF) refined to 1.93 A resolution: multiple copy flexibility and receptor binding.

Y A Muller1, H W Christinger, B A Keyt, A M de Vos.   

Abstract

BACKGROUND: Vascular endothelial growth factor (VEGF) is an endothelial cell-specific angiogenic and vasculogenic mitogen. VEGF also plays a role in pathogenic vascularization which is associated with a number of clinical disorders, including cancer and rheumatoid arthritis. The development of VEGF antagonists, which prevent the interaction of VEGF with its receptor, may be important for the treatment of such disorders. VEGF is a homodimeric member of the cystine knot growth factor superfamily, showing greatest similarity to platelet-derived growth factor (PDGF). VEGF binds to two different tyrosine kinase receptors, kinase domain receptor (KDR) and Fms-like tyrosine kinase 1 (Flt-1), and a number of VEGF homologs are known with distinct patterns of specificity for these same receptors. The structure of VEGF will help define the location of the receptor-binding site, and shed light on the differences in specificity and cross-reactivity among the VEGF homologs.
RESULTS: We have determined the crystal structure of the receptor-binding domain of VEGF at 1.93 A resolution in a triclinic space group containing eight monomers in the asymmetric unit. Superposition of the eight copies of VEGF shows that the beta-sheet core regions of the monomers are very similar, with slightly greater differences in most loop regions. For one loop, the different copies represent different snapshots of a concerted motion. Mutagenesis mapping shows that this loop is part of the receptor-binding site of VEGF.
CONCLUSIONS: A comparison of the eight independent copies of VEGF in the asymmetric unit indicates the conformational space sampled by the protein in solution; the root mean square differences observed are similar to those seen in ensembles of the highest precision NMR structures. Mapping the receptor-binding determinants on a multiple sequence alignment of VEGF homologs, suggests the differences in specificity towards KDR and Flt-1 may derive from both sequence variation and changes in the flexibility of binding loops. The structure can also be used to predict possible receptor-binding determinants for related cystine knot growth factors, such as PDGF.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9351807     DOI: 10.1016/s0969-2126(97)00284-0

Source DB:  PubMed          Journal:  Structure        ISSN: 0969-2126            Impact factor:   5.006


  56 in total

1.  Modeling the early stages of vascular network assembly.

Authors:  Guido Serini; Davide Ambrosi; Enrico Giraudo; Andrea Gamba; Luigi Preziosi; Federico Bussolino
Journal:  EMBO J       Date:  2003-04-15       Impact factor: 11.598

2.  Vascular endothelial growth factor A (VEGF-A) induces endothelial and cancer cell migration through direct binding to integrin {alpha}9{beta}1: identification of a specific {alpha}9{beta}1 binding site.

Authors:  Saji Oommen; Shiv K Gupta; Nicholas E Vlahakis
Journal:  J Biol Chem       Date:  2010-11-11       Impact factor: 5.157

3.  Targeting angiogenesis: structural characterization and biological properties of a de novo engineered VEGF mimicking peptide.

Authors:  Luca Domenico D'Andrea; Guido Iaccarino; Roberto Fattorusso; Daniela Sorriento; Concetta Carannante; Domenica Capasso; Bruno Trimarco; Carlo Pedone
Journal:  Proc Natl Acad Sci U S A       Date:  2005-09-26       Impact factor: 11.205

4.  Structure of a mutant β toxin from Staphylococcus aureus reveals domain swapping and conformational flexibility.

Authors:  Andrew C Kruse; Medora J Huseby; Ke Shi; Jeff Digre; Douglas H Ohlendorf; Cathleen A Earhart
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2011-03-24

5.  Native MS and ECD Characterization of a Fab-Antigen Complex May Facilitate Crystallization for X-ray Diffraction.

Authors:  Ying Zhang; Weidong Cui; Aaron T Wecksler; Hao Zhang; Patricia Molina; Galahad Deperalta; Michael L Gross
Journal:  J Am Soc Mass Spectrom       Date:  2016-04-21       Impact factor: 3.109

6.  Identification of a peptide blocking vascular endothelial growth factor (VEGF)-mediated angiogenesis.

Authors:  R Binétruy-Tournaire; C Demangel; B Malavaud; R Vassy; S Rouyre; M Kraemer; J Plouët; C Derbin; G Perret; J C Mazié
Journal:  EMBO J       Date:  2000-04-03       Impact factor: 11.598

7.  Placental Growth Factor as a Predictor of Cardiovascular Events in Patients with CKD from the NARA-CKD Study.

Authors:  Masaru Matsui; Shiro Uemura; Yukiji Takeda; Ken-Ichi Samejima; Takaki Matsumoto; Ayako Hasegawa; Hideo Tsushima; Ei Hoshino; Tomoya Ueda; Katsuhiko Morimoto; Keisuke Okamoto; Sadanori Okada; Kenji Onoue; Satoshi Okayama; Hiroyuki Kawata; Rika Kawakami; Naoki Maruyama; Yasuhiro Akai; Masayuki Iwano; Hideo Shiiki; Yoshihiko Saito
Journal:  J Am Soc Nephrol       Date:  2015-03-18       Impact factor: 10.121

8.  A humanized anti-VEGF rabbit monoclonal antibody inhibits angiogenesis and blocks tumor growth in xenograft models.

Authors:  Yanlan Yu; Pierre Lee; Yaohuang Ke; Yongke Zhang; Qiu Yu; Jonathan Lee; Mingzhen Li; Jialiang Song; Jungang Chen; Jihong Dai; Fernando Jose Rebelo Do Couto; Zhiqiang An; Weimin Zhu; Guo-Liang Yu
Journal:  PLoS One       Date:  2010-02-05       Impact factor: 3.240

9.  Structural insights into the binding of vascular endothelial growth factor-B by VEGFR-1(D2): recognition and specificity.

Authors:  Shalini Iyer; Paula I Darley; K Ravi Acharya
Journal:  J Biol Chem       Date:  2010-05-25       Impact factor: 5.157

10.  Molecular structure-function relationship of dietary polyphenols for inhibiting VEGF-induced VEGFR-2 activity.

Authors:  Ana B Cerezo; Mark S Winterbone; Christina W A Moyle; Paul W Needs; Paul A Kroon
Journal:  Mol Nutr Food Res       Date:  2015-09-08       Impact factor: 5.914

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.